HUP9801534A2 - N-(klór-fenil)-karbamátok és N-foszfono-glicin-származékok alkalmazása vírusok szaporodásának és rák növekedésének gátlására alkalmas gyógyszerkészítmények előállítására - Google Patents

N-(klór-fenil)-karbamátok és N-foszfono-glicin-származékok alkalmazása vírusok szaporodásának és rák növekedésének gátlására alkalmas gyógyszerkészítmények előállítására

Info

Publication number
HUP9801534A2
HUP9801534A2 HU9801534A HUP9801534A HUP9801534A2 HU P9801534 A2 HUP9801534 A2 HU P9801534A2 HU 9801534 A HU9801534 A HU 9801534A HU P9801534 A HUP9801534 A HU P9801534A HU P9801534 A2 HUP9801534 A2 HU P9801534A2
Authority
HU
Hungary
Prior art keywords
growth
chlorophenylcarbamates
wich
cancers
viruses
Prior art date
Application number
HU9801534A
Other languages
English (en)
Inventor
James Berger Camden
Original Assignee
The Procter & Gamble Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Co. filed Critical The Procter & Gamble Co.
Publication of HUP9801534A2 publication Critical patent/HUP9801534A2/hu
Publication of HUP9801534A3 publication Critical patent/HUP9801534A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány tárgya rákők és tűmőrők növekedését emberben és melegvérűállatőkban gátló őlyan gyógyszerkészítmény, amely (1) (II) általánősképletű N-(klór-fenil)-karbamátők és -tiőkarbamátők -, ahől n = 1-3, Xőxigénatőm vagy kénatőm, és R hidrőgénatőm, alkil-, alkenil-,ciklőhexil-, fenil-alkil-csőpőrt - vagy gyógyszerészetileg elfőgadhatósóik és (2) (I) általánős képletű N-főszfőnő-glicinek - ahől Xhidrőxi-, alkőxi- vagy klórőxi-, alkenil-őxi-, ciklőhexil-őxi-,mőrfőlinő-, pirrőlidinil-, piperidinő-csőpőrt vagy -NHR' általánősképletű csőpőrt, Y és Z egymástól függetlenül hidrőgénatőm vagyalkilcsőpőrt, R hidrőgénatőm, főrmil-, acetil-, benzőil-, nitrő-benzőil- és klórőzőtt benzőilcsőpőrt, és sóik keverékének biztőnságősés hatásős mennyiségét tartalmazza. A készítmények vírűsfertőzésekellen is hatásősak. ŕ
HU9801534A 1995-04-12 1996-04-11 The use of n-chlorophenylcarbamates, and n-phosphonoglycine derivatives for producing pharmaceutical compositions wich are inhibiting the growth of cancers and viruses HUP9801534A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/420,935 US5656615A (en) 1995-04-12 1995-04-12 Pharmaceutical composition for inhibiting the growth of cancers and viruses in mammals

Publications (2)

Publication Number Publication Date
HUP9801534A2 true HUP9801534A2 (hu) 1998-12-28
HUP9801534A3 HUP9801534A3 (en) 1999-03-01

Family

ID=23668465

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9801534A HUP9801534A3 (en) 1995-04-12 1996-04-11 The use of n-chlorophenylcarbamates, and n-phosphonoglycine derivatives for producing pharmaceutical compositions wich are inhibiting the growth of cancers and viruses

Country Status (21)

Country Link
US (1) US5656615A (hu)
EP (1) EP0820282A1 (hu)
JP (1) JPH11503457A (hu)
KR (1) KR19980703805A (hu)
CN (1) CN1181009A (hu)
AR (1) AR003119A1 (hu)
AU (1) AU714058B2 (hu)
BR (1) BR9604950A (hu)
CA (1) CA2217955A1 (hu)
CZ (2) CZ288063B6 (hu)
HU (1) HUP9801534A3 (hu)
IL (1) IL117876A (hu)
NO (1) NO974693L (hu)
NZ (1) NZ306270A (hu)
PL (1) PL322776A1 (hu)
RU (1) RU2170578C2 (hu)
SK (1) SK282228B6 (hu)
TR (1) TR199701150T1 (hu)
TW (1) TW457089B (hu)
WO (1) WO1996032103A1 (hu)
ZA (1) ZA962881B (hu)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
BR9604973A (pt) 1995-04-12 1998-06-09 Procter & Gamble Uma composição farmacêutica contendo carbamatos de n-cloro fenila e tiocarbamatos de n-cloro fenila para inibição de crescimento de vírus e cânceres
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
ZA962879B (en) * 1995-04-12 1997-03-17 Procter & Gamble A pharmaceutical composition for inhibiting the growth of viruses and cancers
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
AU730920B2 (en) * 1995-04-12 2001-03-22 Uaf Technologies And Research Llc A pharmaceutical composition containing N-chlorophenylcarbamates and N-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en) * 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
CN1281127C (zh) * 1995-11-08 2006-10-25 麦克公司 农药制剂
US5900429A (en) * 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
PE11499A1 (es) * 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
PL215317B1 (pl) 1998-08-13 2013-11-29 Bayer Cropscience Ag Zastosowanie kompozycji zawierajacej glifosat i sulkotrion lub mezotrion do zwalczania szkodliwych roslin w uprawach kukurydzy oraz sposób zwalczania szkodliwych roslin w uprawach kukurydzy
US6423734B1 (en) * 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
CA2422524A1 (en) * 2000-09-25 2002-03-28 Motoyuki Yamashita Pei: dna vector formulations for in vitro and in vivo gene delivery
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6515074B2 (en) * 2001-01-22 2003-02-04 Delphi Technologies, Inc. Thermoplastic polymer alloy compositions and process for manufacture thereof
US7441043B1 (en) * 2002-12-31 2008-10-21 At&T Corp. System and method to support networking functions for mobile hosts that access multiple networks

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2734911A (en) * 1956-02-14 Reaction of chloroaniline and isopropyl
US2695225A (en) * 1954-05-21 1954-11-23 Columbia Southern Chem Corp Herbicidal compositions
US3799758A (en) * 1971-08-09 1974-03-26 Monsanto Co N-phosphonomethyl-glycine phytotoxicant compositions
US3853530A (en) * 1971-03-10 1974-12-10 Monsanto Co Regulating plants with n-phosphonomethylglycine and derivatives thereof
US3903297A (en) * 1973-11-01 1975-09-02 Upjohn Co Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs
US4408052A (en) * 1980-02-27 1983-10-04 Takeda Chemical Industries, Ltd. Phospholipid carbamates
JPS5772914A (en) * 1980-10-22 1982-05-07 Takeda Chem Ind Ltd Antitumor agent
EP0061872B1 (en) * 1981-03-30 1985-08-07 Takeda Chemical Industries, Ltd. Ethyleneglycol derivatives, their production and use
JPS6081194A (ja) * 1983-10-11 1985-05-09 Takeda Chem Ind Ltd ケトアルキルリン脂質
JPS6081193A (ja) * 1983-10-11 1985-05-09 Takeda Chem Ind Ltd リン脂質
US4866059A (en) * 1988-04-04 1989-09-12 Warner-Lambert Company '(2S)-(5-amino-1,2-dihydro-2-methyl-3-phenylpyrido(3,4-b)pyrazin-7-yl)-carbamic acid, ethyl ester
US5114951A (en) * 1989-04-11 1992-05-19 Burroughs Wellcome Company Agents for combating multiple drug resistance

Also Published As

Publication number Publication date
IL117876A (en) 2000-08-13
AU5449896A (en) 1996-10-30
TW457089B (en) 2001-10-01
EP0820282A1 (en) 1998-01-28
AU714058B2 (en) 1999-12-16
PL322776A1 (en) 1998-02-16
CZ288063B6 (cs) 2001-04-11
RU2170578C2 (ru) 2001-07-20
KR19980703805A (ko) 1998-12-05
NZ306270A (en) 2001-06-29
CZ323797A3 (cs) 1998-03-18
AR003119A1 (es) 1998-07-08
SK282228B6 (sk) 2001-12-03
NO974693L (no) 1997-12-08
CZ288382B6 (en) 2001-06-13
BR9604950A (pt) 1998-06-09
WO1996032103A1 (en) 1996-10-17
CA2217955A1 (en) 1996-10-17
IL117876A0 (en) 1996-08-04
NO974693D0 (no) 1997-10-10
TR199701150T1 (xx) 1998-03-21
CN1181009A (zh) 1998-05-06
JPH11503457A (ja) 1999-03-26
HUP9801534A3 (en) 1999-03-01
US5656615A (en) 1997-08-12
SK138597A3 (en) 1998-05-06
ZA962881B (en) 1996-10-15

Similar Documents

Publication Publication Date Title
HUP9801534A2 (hu) N-(klór-fenil)-karbamátok és N-foszfono-glicin-származékok alkalmazása vírusok szaporodásának és rák növekedésének gátlására alkalmas gyógyszerkészítmények előállítására
DK0750618T3 (da) Oxazolidinonderivater og farmaceutiske præparater indeholdende dem
HUP0001170A2 (hu) Hatóanyagként enzimidazol-2-karbamát-származékokat tartalmazó, vírusfertőzések és rák kezelésére alkalmas gyógyszerkészítmények
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
HU914153D0 (en) Electrically operated lock
FI913478A0 (fi) Diazinderivat.
TW427887B (en) Pharmaceutical composition comprising a benzimidazole derivative for treating viral infections
FI962952A (fi) Delta 12,13-iso-taksolianalogit, niiden antineoplastinen käyttö ja niitä sisältävät farmaseuttiset koostumukset
HUP9901586A2 (hu) Antifungális szert és acetátpuffert tartalmazó készítmények és alkalmazásuk
DE60229046D1 (de) Chinazolin derivate
HUP9801356A2 (hu) Triciklusos (2-hidroxi-2-metil-3,3,3-trifluor-propanoil)-amino-benzoxepin-, -benzotiepin-, -benzocikloheptén-, -indén-származékok és az ezeket tartalmazó gyógyszerkészítmények
DK581889A (da) Antiatherosclerotiske diarylforbindelser
HUP9903506A2 (hu) Grizeofulvin felhasználása rákok növekedésének gátlására
HUP9900901A2 (hu) N-(Klór-fenil)-karbamátokat és N-(klór-fenil)-tiokarbamátokat tartalmazó, rákellenes és vírusok szaporodását gátló gyógyszerkészítmény
NO178261C (no) Substituerte diaminoftalimider og analoger, farmasöytiske preparater inneholdende dem samt deres anvendelse i medikamenter
HUP9700436A1 (hu) Triazingyűrűt tartalmazó anionos vegyületek antivirális hatással
NZ308398A (en) 2-amino benzoxazin-4-one derivatives and medicaments
DE69312567T2 (de) 2-Formylpyridin-Thiosemicarbazonderivate, ihre Herstellung und ihre Verwendung als Antitumor Mittel
DE69330601D1 (de) Serotoninergische ergolin derivate
ES8604843A1 (es) Un metodo para la preparacion de un derivado de acetileno
NO950177D0 (no) Farmakologisk aktive erivater
FI955142A (fi) Bentso(f)kinoksaliinidionijohdannaisia, niiden valmistus ja käyttö lääkkeinä
GB2340490A (en) Diphenylacetic acid derivatives and their use as antiviral agents
JO1697B1 (en) Pyridine derivatives